Creatv Bio’s LifeTracDx® Liquid Biopsy Predicts Response to New Line of Therapy for Metastatic Breast Cancer within 30 Days
Results to be presented at ASCO 2022 Annual Meeting in Chicago, IL ROCKVILLE, Md.–(BUSINESS WIRE)–Creatv Bio, Division of Creatv MicroTech, Inc., announced today the release of an abstract featuring the results of its LifeTracDx® blood test for predicting response of metastatic breast cancer (mBC) to new lines of therapy following a single cycle of therapy … [Read more…]